StonvexLoading…
StonvexStonvexStonvexCore line items from RUN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $768.54M | $722.23M | $2.96B | $1.80B | $1.07B |
Operating Income | Not available | $-43.51M | $-126.13M | $-223.49M | $-227.14M |
Net Income | Not available | $167.64M | $449.95M | $346.37M | $329.78M |
EPS (Diluted) | $0.25 | $0.62 | $1.71 | $1.33 | $1.28 |
Total Assets | Not available | $22.77B | $22.61B | $22.23B | $21.23B |
Total Liabilities | Not available | $17.81B | $17.63B | $17.58B | $16.78B |
Cash & Equivalents | Not available | $1.09B | $1.24B | $1.16B | $1.01B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 235.51M | 233.61M | 231.60M | 230.32M |